Hyundai Pharm (004310) — Cash Flow-to-Debt Ratio

Latest as of February 2026: 0.00x

Hyundai Pharm (004310) has a Cash Flow-to-Debt Ratio of 0.00x as of February 2026, meaning its operating cash flow of ₩188.28 Million could theoretically repay 0% of its total liabilities (₩89.49 Billion) in one year. Explore 004310 long-term investment intensity to see how much of total assets are deployed in long-term investments.

CF-to-Debt Ratio

0.00x
Operating CF / Total Liabilities

Operating Cash Flow

₩188.28 Million
KRW

Total Liabilities

₩89.49 Billion
KRW

Data as of

Feb 2026
Most recent filing

Hyundai Pharm Cash Flow-to-Debt Ratio (2010–2025)

Historical debt coverage capacity for Hyundai Pharm across 14 annual periods. Also explore 004310 total asset value for the complete picture of this company's asset base.

Annual Cash Flow-to-Debt Ratio for Hyundai Pharm (2010–2025)

Year-by-year debt coverage analysis for Hyundai Pharm. For market capitalisation and broader financial context, see 004310 market cap.

Year CF-to-Debt Ratio Operating CF (KRW) Total Liabilities YoY Change
2025 0.00x ₩-123.29 Million ₩81.11 Billion ▲ +95.0%
2024 -0.03x ₩-2.37 Billion ₩77.32 Billion ▲ +52.8%
2023 -0.06x ₩-4.55 Billion ₩69.97 Billion ▼ -152.9%
2022 0.12x ₩11.62 Billion ₩94.60 Billion ▲ +85.0%
2021 0.07x ₩5.13 Billion ₩77.26 Billion ▼ -58.6%
2020 0.16x ₩10.80 Billion ₩67.36 Billion ▲ +33.4%
2019 0.12x ₩6.96 Billion ₩57.89 Billion ▲ +119.8%
2018 0.05x ₩2.83 Billion ₩51.80 Billion ▲ +256.1%
2017 -0.04x ₩-1.98 Billion ₩56.52 Billion ▲ +35.6%
2016 -0.05x ₩-2.75 Billion ₩50.47 Billion ▼ -128.9%
2013 0.19x ₩7.95 Billion ₩42.19 Billion ▲ +450.9%
2012 -0.05x ₩-2.70 Billion ₩50.22 Billion ▼ -145.1%
2011 0.12x ₩6.27 Billion ₩52.63 Billion ▲ +71.1%
2010 0.07x ₩2.68 Billion ₩38.48 Billion —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.